415: Does Adjuvant BCG Therapy Reduce the Incidence or Time to Recurrence in Upper Tract Transitional Cell Carcinoma? A 20 Year Experience

Abstract

You have accessJournal of UrologyModerated Poster 13, Sunday, May 20, 2007, 1:00 - 3:00 pm1 Apr 2007415: Does Adjuvant BCG Therapy Reduce the Incidence or Time to Recurrence in Upper Tract Transitional Cell Carcinoma? A 20 Year Experience Ardeshir R. Rastinehad, Michael C. Ost, Kathryn L. Greenberg, Brian A. VanderBrink, Benjamin R. Lee, Gopal H. Badlani, and Arthur D. Smith Ardeshir R. RastinehadArdeshir R. Rastinehad More articles by this author , Michael C. OstMichael C. Ost More articles by this author , Kathryn L. GreenbergKathryn L. Greenberg More articles by this author , Brian A. VanderBrinkBrian A. VanderBrink More articles by this author , Benjamin R. LeeBenjamin R. Lee More articles by this author , Gopal H. BadlaniGopal H. Badlani More articles by this author , and Arthur D. SmithArthur D. Smith More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(18)30668-2AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "415: Does Adjuvant BCG Therapy Reduce the Incidence or Time to Recurrence in Upper Tract Transitional Cell Carcinoma? A 20 Year Experience." The Journal of Urology, 177(4S), p. 138 © 2016 by American Urological AssociationFiguresReferencesRelatedDetails Volume 177Issue 4SApril 2007Page: 138 Advertisement Copyright & Permissions© 2016 by American Urological AssociationMetricsAuthor Information Ardeshir R. Rastinehad More articles by this author Michael C. Ost More articles by this author Kathryn L. Greenberg More articles by this author Brian A. VanderBrink More articles by this author Benjamin R. Lee More articles by this author Gopal H. Badlani More articles by this author Arthur D. Smith More articles by this author Expand All Advertisement PDF downloadLoading ...